89 results
S-8 POS
AMTI
Applied Molecular Transport Inc.
2 Jan 24
Registration of securities for employees (post-effective amendment)
9:14am
Plan”), 314,006 shares of Common Stock issuable under the Company’s 2020 Employee Stock Purchase Plan (the “2020 ESP Plan”), 3,273,506 shares under
S-8 POS
AMTI
Applied Molecular Transport Inc.
2 Jan 24
Registration of securities for employees (post-effective amendment)
9:13am
Plan”), 314,006 shares of Common Stock issuable under the Company’s 2020 Employee Stock Purchase Plan (the “2020 ESP Plan”), 3,273,506 shares under
S-8 POS
AMTI
Applied Molecular Transport Inc.
2 Jan 24
Registration of securities for employees (post-effective amendment)
9:13am
Plan”), 314,006 shares of Common Stock issuable under the Company’s 2020 Employee Stock Purchase Plan (the “2020 ESP Plan”), 3,273,506 shares under
8-K
EX-3.1
AMTI
Applied Molecular Transport Inc.
27 Dec 23
Completion of Acquisition or Disposition of Assets
3:49pm
or she is or was a director, officer, employee or agent of the Corporation or is or was serving at the request of the Corporation as a director, officer … , employee or agent of another corporation, partnership, joint venture, trust or other enterprise, including service with respect to employee benefit
DEFM14A
AMTI
Applied Molecular Transport Inc.
21 Nov 23
Proxy related to merger
9:16am
to, and contingent upon, the closing of the Merger; and
at the closing of the Merger, the unvested options held by AMTI’s non-employee directors will accelerate … vesting, subject to the applicable non-employee director’s continued service as a non-employee director through such date.
For additional details about
425
vwafao
21 Sep 23
Business combination disclosure
5:12pm
8-K
EX-10.1
afiv3z63h03
21 Sep 23
Cyclo Therapeutics, Inc. and Applied Molecular Transport Inc. Enter into a Definitive Merger Agreement
5:10pm
8-K
EX-2.1
3xcr3gs3mts 8dzqhy
21 Sep 23
Cyclo Therapeutics, Inc. and Applied Molecular Transport Inc. Enter into a Definitive Merger Agreement
5:10pm
8-K
EX-99.1
aqi3n6ia r82600q
14 Aug 23
Applied Molecular Transport Reports Second Quarter 2023 Financial Results
4:06pm
8-K
EX-10.1
xxrimgm8wsfhg
24 Jul 23
Departure of Directors or Certain Officers
4:01pm